Seer, Inc. (SEER) NASDAQ
1.79
+0.02(+1.13%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.79
+0.02(+1.13%)
Currency In USD
| Previous Close | 1.77 |
| Open | 1.79 |
| Day High | 1.8 |
| Day Low | 1.72 |
| 52-Week High | 2.41 |
| 52-Week Low | 1.65 |
| Volume | 559,403 |
| Average Volume | 390,765 |
| Market Cap | 98.42M |
| PE | -1.44 |
| EPS | -1.24 |
| Moving Average 50 Days | 1.81 |
| Moving Average 200 Days | 1.96 |
| Change | 0.02 |
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
GlobeNewswire Inc.
Feb 26, 2026 9:06 PM GMT
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously adopted a tax benefit preservation pla
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
GlobeNewswire Inc.
Feb 19, 2026 12:00 PM GMT
Nathan Basisty, Sasha Singh, Bruce Wilcox, and Mozhgan Boroumand among scientific leaders presenting unique proteomics-enabled biological insightsREDWOOD CITY, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and tru
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 18, 2026 9:05 PM GMT
REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming TD Cowen 46th Annual He